CrossrefInfokarte
Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab
Pediatric Allergy and Immunology · 2026-11 · 37 (11)
DOI: 10.1111/pai.70523 ↗Abstract
Kein Abstract verfügbar.
EUVIMED